SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

BIO Biome Australia Limited

Consumer Defensive · Packaged Foods · website
$0.42
52wk 0.20 – 0.51
Overall
75.7
Value
38.8
Growth
100.0
Health
86.5
Quality
60.1
Momentum
93.9
Dividend
—
Price
About Biome Australia Limited

Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.

Price analytics

Returns

1 day 5.0%
1 week 3.7%
1 month 18.3%
3 months 58.5%
6 months 27.3%
1 year -13.4%
3 years 200.0%

Risk

Volatility (1y ann.) 64.9%
Beta vs ASX 200 0.85
Sharpe (1y) 0.03
VaR 95% (1-day) -5.6%
Max drawdown (1y) -54.1%
Off 1-year high -14.3%

Technicals

RSI(14) 68
vs 50DMA 26.2%
vs 200DMA 23.3%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 38.8
Trailing P/E
59
Forward P/E
65
PEG ratio
—
EV / EBITDA
0
Price / Book
0
Price / Sales
64
Growth 100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health 86.5
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
78
Debt / Equity
94
Quality (Profitability & Cash Flow) 60.1
Return on equity
100
Return on assets
26
Operating margin
0
Net margin
100
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 93.9
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
100
Position in 52-week range
71

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$97.19M
P/E (trailing)
21.00
P/E (forward)
17.50
EPS (trailing)
0.02
Dividend yield
—
Payout ratio
0.0%
Beta
0.99
EV / EBITDA
129.47
Price / Book
10.24
ROE
51.3%
Operating margin
-0.4%
Net margin
15.1%
Total cash
$3.55M
Total debt
$2.97M
Current ratio
2.12
Debt / Equity
0.32
Free cash flow
$318,449
Avg volume
237,901
Latest annual results (FY ending 30 Jun 2025)
  • Revenue—
  • Gross profit—
  • Operating income—
  • Net income—
  • Diluted EPS0.00
  • Free cash flow—
  • Net debt—
Sector peers (Consumer Defensive)
TickerMkt cap P/EScore
WOW $46.85B 41.7 35.9
COL $30.95B 28.4 42.5
EDV $5.35B 99.3 24.2
A2M $4.86B 29.0 48.3
TWE $4.54B — 51.6
MTS $3.18B 11.6 48.9
BGA $1.92B 34.8 44.4
GNC $1.43B — 35.9